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Abstract: Background: Functional (psychogenic) neurological disorders (FNDs) are common and should be diagnosed using positive diagnostic features of internal inconsistency. However, there is a lack of objective data regarding motor signs and a lack of signs relating to motor disorders that affect the upper body and neck. The objective of this study was to provide specificity and sensitivity data on 2 axial motor signs: the sternocleidomastoid (SCM) and platysma signs.
Methods: Thirty patients with motor FNDs according to the Diagnostic and Statistical Manual of Mental Disorders, fifth edition, and 40 organic controls with unilateral weakness were prospectively included. The SCM functional sign and platysma organic signs were systematically tested and compared between groups.
Results: The SCM sign had high specificity of 90% (confidence interval [CI] , 77%-96%) to detect FND when the platysma sign had 100% specificity (CI, 88%-100%) for detecting organic weakness. The co-occurrence of a positive SCM and a negative platysma sign in patients with unilateral weakness carried 95% specificity (CI, 83%-99%) and 63% sensitivity (CI, 44%-80%).
Conclusion:
The SCM test and platysma signs can be used for the diagnosis of motor FND. The extent to which these add value to other validated signs (such as Hoover's sign) should be further evaluated.
Interest in functional symptoms in neurology has reemerged in recent years 1,2 alongside attempts to better validate bedside signs. 3, 4 To diagnose functional paresis, it is important, but not sufficient, to exclude organic signs (like Babinski's plantar reflex); it is also necessary to demonstrate the presence of "positive" functional signs, 5 such as Hoover's sign of lower limb weakness, 6 or the hip abductor sign, 7 drift without pronation, 8 or give-way weakness. 9 The clinical utility of these signs has been studied, 4 but little literature is available on axial signs (i.e.,
signs not lateralized to a limb). Thus, our aim was to select axial signs and conduct a validation study of their clinical utility. The 3 main axial signs described are the sternocleidomastoid (SCM), 10 platysma, 11 and trunk-thigh 4,11 signs. The SCM sign, tested by Russian researchers, 10, 12 suggests that asymmetric weakness of head rotation, with weakness of head turning toward the side of a hemiparesis, represents a positive sign of a functional disorder. If such weakness in hemiparesis is due to a structural cause, such as stroke, then the neck is weak turning away from the affected arm and leg. Babinski proposed 2 tests, other than the plantar reflex, as positive indicators of organic rather than functional paresis. 11 He wrote, "It is in organic hemiplegia that I observed this disorder, which consists, in certain actions involving the platysma, of a more energetic contraction of this muscle on the healthy side than the paralyzed side." This suggests that asymmetry of platysma contraction represents a positive organic sign. He also described the trunk-thigh test as a positive sign of organic hemiparesis in which the weak leg is elevated when attempting to sit up from a lying position in organic hemiparesis compared with the leg staying on the bed in functional hemiparesis. We observed, in a previous study, that the SCM test interrater reliability was excellent (Cohen d = 0.83), 9 reliability are available, but we hypothesized that, while looking at head rotation (SCM), the platysma sign is a valuable additional sign, because it examines the same anatomic region.
To assess the clinical value of the SCM and platysma signs in terms of specificity and sensitivity, we set out to systematically test them in a group of patients who had functional and organic hemiparesis.
Patients and Methods

Patients
Thirty patients with a diagnosis of conversion disorder (FND) and 40 patients with a known neurological (organic) condition (34 with stroke, 3 with multiple sclerosis, 2 with meningoencephalitis, and 1 with cerebral palsy) were prospectively included at Geneva and Lausanne University hospitals from July 2014 to August 2016. Functional patients were diagnosed according to Diagnostic and Statistical Manual of Mental Disorders, fifth edition criteria (known positive signs, such as the Hoover's sign, give-away weakness, or motor inconsistency, were used, but not the SCM sign or the platysma sign), and organic patients were diagnosed based on clinical features, radiologic imaging, blood tests, and lumbar puncture when needed. Inclusion criteria were the presence of unilateral limb paresis of an arm and/or leg measurable on the Medical Research Council (MRC) scale (scores of <5 vs. 5). Exclusion criteria were age younger than 18 years, an orthopedic disorder interfering with motor testing, and severe cognitive impairment. Institutional review board and ethical approval was obtained for the study protocol (CER Geneva HUG 14-088), and all participants provided a signed, written informed consent form before inclusion.
Procedure
Patients were examined (by D.H., S.G., or S.A.) using a standardized protocol to assess for SCM and platysma signs. Patients were evaluated in a sitting position in front of the examiner. They turned their head toward each side, against the examiner's resistance, for 5 seconds. The SCM sign was considered as a positive functional sign if a difference in strength was observed between the 2 sides, and the side of weakness was recorded (leftward weakness representing right SCM weakness, and vice versa). Then, participant was asked to open their mouth wide and flex their head toward the chin against the examiner's resistance on their forehead. The platysma sign was considered as a positive organic sign in the presence of observed platysma asymmetric contraction. In addition, limb muscle strength was measured according to the National Institutes of Health Stroke Scale 13 score for the arm (item 5) and leg (item 6; scored from
Statistical Analyses
The occurrence of each sign was compared between groups (2-tailed Fisher tests), and their sensitivity and specificity were calculated (http://www.openepi.com). We repeated this analysis after removing the participants who presented with only lower limb paresis, because we hypothesized that the signs may be more useful in patients suffering from upper limb weakness. 12 In the clinic, we hypothesized that it would be useful to identify patients who displayed both a negative platysma sign (no sign of organic disorder) AND a positive SCM sign (sign of functional disorder). Therefore, we also calculated the specificity and sensitivity of this association of signs.
Results
Clinical and demographic data are presented in Table 1 
SCM Functional Sign
Nineteen of 30 patients with FND (63%) had a positive SCM sign versus 4 of 40 patients with organic signs (10%; P < 0.05) ( Table 2 ). The sensitivity was 63% (CI, 46%-78%), and specificity was 90% (CI, 77%-96%). After removing the 6 participants who had pure leg weakness, x/y (69%) of patients with FND (x%; P < 0.001) had a positive sign, reaching a sensitivity of 69% (CI, 50%-84%) with almost the same specificity (89%, CI, 76%-95%).
Among the 19 functional patients with a positive SCM sign, 17 (90%) had a weakness in rotating the head toward the weak side of the body. Among the 4 patients with organic signs who had a positive SCM sign, all (100%) had a weakness in rotating the head toward the weak side of the body.
Platysma Organic Sign
Nine of 40 patients with organic signs (22.%) had an asymmetry of platysma contraction, whereas none of the patients with FND (0%; P < 0.05) showed this asymmetry. Therefore, the specificity of this organic sign was 100% (CI, 88%-100%), but the sensitivity was only 23% (CI, 11%-38%).
Combining SCM and Platysma Signs
Among the patients with FND, 19 had both a negative platysma sign and a positive SCM sign (63%). Among the patients with organic signs, 2 had both a negative platysma sign and a positive SCM sign (5%). Therefore, the combination of these signs represented 95% specificity (CI, 83%-99%) and 63% sensitivity(CI, 44%-80%).
Discussion
Our study shows that testing head rotation and flexion in patients with unilateral motor paresis can be helpful: finding a weakness of head rotation together with symmetrical platysma contraction strongly suggests an FND with 95% specificity. For clinicians, it is important to use highly specific signs-more than sensitive signs-to correctly identify true-negative results (that is, to identify patients who have true organic signs) and reduce the false-positive rate. This ensures that patients are not mislabeled with FND when they have an organic condition, which has been a concern for many neurologists for a long time. [14] [15] [16] These data compare with previous findings 9,10 of 80% (24 of 30 patients) positive SCM signs in functional patients versus 11% (3 of 24 patients) in organic controls (87.5% specificity, 80% sensitivity), as well as our previous cohort with 35% (7 of 20 patients) positive SCM signs in patients with FND versus 0% (0 of 20 patients) in organic controls (100% specificity, 31% sensitivity). The SCM muscle is the main head rotator and is innervated by a cranial nerve (the 11th accessory nerve), unlike other neck muscles, which receive cervical root innervation. The peculiarity of the SCM is its ipsilateral cortical control (a right hemispheric lesion can affect the right SCM muscle, thus affecting leftward head rotation, and tends to cause head turning away from the affected side). Evidence from such ipsilateral control comes from observations in epilepsy of head movements directed away from the irritative focus. 17 The excitatory effect causes contralateral, dystonic posturing and head deviation due to contraction of the ipsilateral SCM. The first explanation for this ipsilateral control was an undecussated corticospinal tract, 18 but later evidence indicated a double decussation pathway, 19 first in the pons and then in the spinal cord (Fig. 2) . Our finding of reduced SCM strength when rotating the head toward the weak side of the body (SCM muscle contralateral to the weak side), both in patients with FND (90%) and in those with organic signs (100%), is in agreement with this ipsilateral control. In a series of 124 stroke patients, 17% had ipsilateral SCM weakness, 20, 21 which is comparable to the 10% rate (4 of 40 patients) we observed. This rate contrasts with the 63 to 100% rate observed in functional patients and suggests that this pattern of unilateral head rotation weakness is more specific to functional than organic patients. One can hypothesize that in organic patients, the frequency of SCM weakness is low because head rotation is partly compensated by other muscles (like splenius capiti) minimizing the influence of the central lesion. In functional disorders, it has been suggested that the pattern of neurological deficit reflects the mental representation of a deficit, 22 of an "a priori expectation" from the patient of what a paresis should look and feel like, rather than a pattern governed by anatomical rules. Other arguments for the role of a priori expectation that the whole hemibody is affected in FND, the finding in some patients of difficulties directing gaze 23 toward the hemiparetic side and complete midline hemisensory loss on the paretic side. 23, 24 There are no other controlled data regarding the platysma sign with which to compare our findings. Our study has some limitations. First, the examiners were not blinded to the participants' diagnosis, and this may have biased the interpretation of the sign. The SCM sign had good interrater reliability on blinded ratings of video-taped interviews. 24 For the platysma sign, no such data are available, and we cannot suggest the effect of an unblinded evaluation. Because gold standards for both functional and organic diagnoses are clinical, misdiagnoses cannot be ruled out with certainty in any group. However, the misdiagnosis rate in functional disorder is generally low (0.4%). 15, 25, 26 All of our patients with organic signs underwent paraclinical examinations to confirm the diagnosis (imaging, cerebrospinal fluid analysis), but functional overlay is possible. In addition, the diagnosis of functional paresis was not established with the help of the 2 signs used in this study, which avoids a diagnostic suspicion bias. Second, our 2 samples demonstrated differences in age, sex, and symptom duration, which are explained by the studied populations (younger age, female preponderance, and longer symptom duration were more frequent in patients with FND than organic controls [mostly patients with stroke]). To our knowledge, however, there is no evidence in the literature suggesting that age, sex, or symptom duration should influence the incidence of positive signs, and we do not expect significant biases. Third, our samples differed in terms of weakness severity (less severe in patients with organic signs), but the difference was not significant for arm weakness, and the SCM sign was still highly specific after excluding patients with only leg weakness.
Overall, our results suggest that testing head rotation and flexion can add to the clinical evaluation of patients with suspected FND. Future studies should add 2 signs: (1) trapezius testing (also innervated by the 11th accessory nerve but with a single decussation and thus with contralateral cortical control), because it can help localize the lesion in organic patients 27 ; and (2) head lateral flexion as a weakness is not found in stroke 21 but could be frequent in FND and confirm the hypothesis of an "a priori" dysfunction of all muscles directed at moving the body on 1 side.
In conclusion, asymmetry of head rotation strength in the presence of symmetric platysma contraction should be interpreted as strongly suggesting a functional paresis in patients with unilateral limb weakness. This association of signs is more useful for upper limb weakness but its additional diagnostic value when present with other positive motor signs, such as the Hoover sign requires further evaluation. 
